- Report
- August 2025
- 193 Pages
Global
From €3498EUR$3,939USD£3,038GBP
- Report
- August 2025
- 183 Pages
Global
From €3498EUR$3,939USD£3,038GBP
- Report
- August 2025
- 193 Pages
Global
From €3498EUR$3,939USD£3,038GBP
- Report
- August 2025
- 187 Pages
Global
From €3498EUR$3,939USD£3,038GBP
- Report
- November 2025
- 150 Pages
Global
From €5284EUR$5,950USD£4,588GBP
- Report
- April 2025
- 147 Pages
Global
From €2663EUR$2,999USD£2,313GBP
- Report
- March 2025
- 149 Pages
Global
From €2663EUR$2,999USD£2,313GBP
- Report
- January 2025
- 132 Pages
Global
From €2663EUR$2,999USD£2,313GBP
- Report
- August 2025
- 192 Pages
Global
From €3498EUR$3,939USD£3,038GBP
- Report
- October 2025
Global
From €4352EUR$4,900USD£3,779GBP
- Report
- January 2026
- 471 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 197 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 189 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 177 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 486 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 368 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 288 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 279 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 476 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 375 Pages
Global
From €5195EUR$5,850USD£4,511GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more